Microbiota-reactive T cells trigger colitis in mice harboring the microbiota of wild-caught mice following CTLA-4 blockade, according to a new study that reveals a major mechanism by which anti-CTLA-4 ...
Immune checkpoint inhibitors in advanced malignant peritoneal mesothelioma: Clinical insights, immunopathologic profiling, and prognostic implications from a single-center study. Testing scores from ...
Fecal microbiota transplantation is an emerging strategy for modulating the gut microbiome to influence immunotherapy ...
Specialists discuss adverse reactions to immunotherapy and explore the importance of CTLA-4 inhibitors in mNSCLC treatment. Mark Socinski, MD: As I mentioned before, we’ve seen a step up in outcomes ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a ...
Breakthrough in resistance: Mount Sinai scientists discovered a method to restore immune cell communication, tackling colorectal cancer's resistance to current immunotherapies. Combination therapy ...
Among the most challenging are mutations in KEAP1 and STK11, which are frequently associated with a "cold" tumor ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vicero, Inc., a preclinical-stage biopharmaceutical company developing next-generation VINCOBODIES for immune-mediated diseases, today announced compelling safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results